Evolutionary genetic and experimental analyses suggest that mutations causing familial Mediterranean fever have been positively selected in the Middle East, probably because they confer heightened resistance against Yersinia pestis infection.
References
Koshy, R., Sivadas, A. & Scaria, V. Clin. Genet. 93, 92–102 (2018).
Schnappauf, O., Chae, J. J., Kastner, D. L. & Aksentijevich, I. Front. Immunol. 10, 1745 (2019).
Chung, L. K. et al. Cell Host Microbe 20, 296–306 (2016).
Park, Y. H. et al. Nat. Immunol. https://doi.org/10.1038/s41590-020-0705-6 (2020).
Pettenkofer, H. J., Stoess, B., Helmbold, W. & Vogel, F. Nature 193, 445–446 (1962).
Elvin, S. J. et al. Nature 430, 418 (2004).
Springer, G. F. & Wiener, A. S. Nature 193, 444–445 (1962).
Mecsas, J. et al. Nature 427, 606 (2004).
Voight, B. F., Kudaravalli, S., Wen, X. & Pritchard, J. K. PLoS Biol. 4, e72 (2006).
Barreiro, L. B. & Quintana-Murci, L. Nat. Rev. Genet. 11, 17–30 (2010).
Dehasque, M. et al. Evol. Lett. 4, 94–108 (2020).
Spyrou, M. A., Bos, K. I., Herbig, A. & Krause, J. Nat. Rev. Genet. 20, 323–340 (2019).
Randremanana, R. et al. Lancet Infect. Dis. 19, 537–545 (2019).
Acknowledgements
My laboratory is supported by the Institut Pasteur, the CNRS, the French Government’s Investissement d’Avenir program, Laboratoires d’Excellence “Integrative Biology of Emerging Infectious Diseases” (ANR-10-LABX-62-IBEID) and “Milieu Intérieur” (ANR-10-LABX-69-01) projects, the Fondation pour la Recherche Médicale (Equipe FRM DEQ20180339214) and the Agence Nationale de la Recherche grant ‘MORTUI’ (ANR-19-CE35-0005-01).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Patin, E. Plague as a cause for familial Mediterranean fever. Nat Immunol 21, 833–834 (2020). https://doi.org/10.1038/s41590-020-0724-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0724-3
- Springer Nature America, Inc.